BKM Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$309K Hold
1,180
– – 0.1% 131
2026
Q2
$297K Hold
1,180
– – 0.11% 127
2026
Q1
$257K Sell
1,180
-268
-19% -$59.4K 0.09% 134
2025
Q4
$331K Hold
1,448
– – 0.12% 119
2025
Q3
$335K Hold
1,448
– – 0.12% 121
2025
Q2
$269K Sell
1,448
-1
-0.1% -$186 0.11% 134
2025
Q1
$304K Sell
1,449
-366
-20% -$71.2K 0.13% 127
2024
Q4
$323K Buy
1,815
+306
+20% +$56.3K 0.13% 128
2024
Q3
$298K Buy
+1,509
New +$282K 0.12% 133
2024
Q2
– Sell
-1,754
Closed -$319K – 140
2024
Q1
$319K Buy
1,754
+246
+16% +$42.4K 0.14% 129
2023
Q4
$234K Buy
+1,508
New +$220K 0.1% 146

Other funds holding ABBV

BKM Wealth Management's ABBV Position: Q3 2026 in Review

BKM Wealth Management held its AbbVie (ABBV) position steady in Q3 2026 at 1,180 shares worth $309K. The position accounts for 0.1% of the portfolio, ranked #131.

BKM Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $335K in Q3 2025. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • BKM Wealth Management held 1,180 shares of AbbVie worth $309K as of Q3 2026.
  • BKM Wealth Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.1% of BKM Wealth Management's portfolio in Q3 2026, its #131 holding.
  • BKM Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • BKM Wealth Management's AbbVie position peaked at $335K in Q3 2025.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BKM Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.